{"id":52183,"date":"2015-01-06T12:06:00","date_gmt":"2015-01-06T12:06:00","guid":{"rendered":"http:\/\/mostafa.openonline.co.uk\/?guid=21f40f4dcb140f127bd5e19ebbc17eb9"},"modified":"2015-01-06T12:06:00","modified_gmt":"2015-01-06T12:06:00","slug":"press-release-new-essential-orange-and-green-guides-2015-out-now","status":"publish","type":"post","link":"https:\/\/mostafa.openonline.co.uk\/?p=52183","title":{"rendered":"Press release: New essential Orange and Green Guides 2015 \u2013 out now!"},"content":{"rendered":"
\n

The latest UK pharmaceutical regulations, EU directives and guidance for manufacturers and distributors of human medicines, known as the Orange and Green Guides, compiled by the Medicines and Healthcare products Regulatory Agency (MHRA<\/abbr>), are available to buy now. These are an essential purchase for anyone subject to good manufacturing practice (GMP<\/abbr>) and good distribution practice (GDP<\/abbr>) in Europe.<\/p>\n

The Orange Guide (Rules and Guidance for Pharmaceutical Manufacturers and Distributors)<\/a> contains information and legislation relating to the manufacture and distribution of human medicines. The Green Guide (Rules and Guidance for Pharmaceutical Distributors)<\/a> provides information on the broader distribution. <\/p>\n

Mark Birse, MHRA<\/abbr> GMDP Group Manager, IE&S said:<\/p>\n

\n

The Orange and Green Guides are essential tools in helping companies understand the regulatory environment in which they operate, follow good practice and stay compliant with the law.<\/p>\n

This is key to ensuring that safe and high quality medicines for people are being made and distributed, providing the trust needed by patients and healthcare professionals to use them.<\/p>\n<\/blockquote>\n

The new 2015 edition of the Orange Guide includes changes made to European Community guidelines on GMP<\/abbr> and the revised EU Guidelines on GDP<\/abbr>. <\/p>\n

There are new sections on: <\/p>\n